Assessment of somatostatin receptor expression in predicting results of PRRT (peptide receptor radionuclide therapy) in disseminated neuroendocrine tumours (NET)

被引：0
|
作者：
Hubalewska-Dydejayk, Alicja B. [1 ]
Sowa-Staszczak, Anna [1 ]
Trofimiuk, Malgorzata [1 ]
Stefanska, Agnieszka [1 ]
Wierzchowski, Wojciech [2 ]
Kunikowska, Jolanta [3 ]
Pach, Dorota [1 ]
Tomaszewska, Romana [2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Nucl Med Unit, Dept Endocrinol, Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Pathol, Krakow, Poland
[3] Med Univ, Dept Nucl Med, Warsaw, Poland
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [31] Medical and Peptide Receptor Radionuclide Therapy (PRRT) with Somatostatin Analogues (SSA) in Well- and Moderately Differentiated Neuroendocrine Tumors
    Bianchi, A.
    Iacovazzo, D.
    Fusco, A.
    Lugli, F.
    Giampietro, A.
    Lorusso, M.
    D'Uonnolo, A.
    Perotti, G.
    Pontecorvi, A.
    De Marinis, L.
    NEUROENDOCRINOLOGY, 2011, 94 : 16 - 17
  • [32] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Samuel Adant
    Girish M. Shah
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 907 - 921
  • [33] Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
    Elston, Marianne S.
    Love, Amanda
    Kevat, Dev
    Carroll, Richard
    Siow, Zhen Rong
    Pattison, Sharon
    Boyle, Veronica
    Segelov, Eva
    Strickland, Andrew H.
    Wyld, David
    Gauci, Richard
    Kennedy, Kim
    Ransom, David
    CANCER MEDICINE, 2021, 10 (23): : 8405 - 8411
  • [34] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
    Filice, Angelina
    Fraternali, Alessandro
    Fioroni, Federica
    Froio, Armando
    Di Paolo, Maria Liberata
    Casali, Massimiliano
    Roncali, Massimo
    Grassi, Elisa
    Asti, Mattia
    Versari, Annibale
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [35] Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours
    Prospero, I.
    Ferreira, G.
    Ferro, J. C.
    Barbosa, D.
    Silva, D. G.
    Fontao de Castro, S.
    Teixeira, J. P.
    Duarte, H.
    Lucena Sampaio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S220 - S220
  • [36] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Michael S. Hofman
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 211 - 213
  • [37] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Hofman, Michael S.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 211 - 213
  • [38] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Adant, Samuel
    Shah, Girish M.
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 907 - 921
  • [39] Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status
    Moncayo, Roy
    Traeger, Annette
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (08) : 1580 - 1581
  • [40] Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status
    Roy Moncayo
    Annette Traeger
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1580 - 1581
12345